Archive: Transplantation of Embryonic Neurons Raises Hope for Treating Brain Diseases
University of California San Francisco
Give to UCSF
Displaying 8821 - 8850 of 16911
-
-
Archive: Among Disciplined Nurse Aides, Criminal Records Turn Up
-
Archive: UCSF's LGBTQ Community Assures Teens That 'It Gets Better'
<p>To increase awareness about the "coming out" process, members of UCSF’s LGBTQ community created an “It Gets Better” video to commemorate National Coming Out Day on October 11.</p>
-
Archive: Yamanaka's Nobel Prize Highlights Value of Training and Collaboration
<p>When Shinya Yamanaka won the Nobel Prize in Medicine, colleagues at UCSF and the Gladstone Institutes and scientists from his lab gathered Monday afternoon to cheer the laureate and raise champagne toasts, while he shared in the celebration via live video streaming from halfway across the globe.</p>
-
Archive: Top Students Tell Why They Chose UCSF
<p>Top students from UCSF's four professional schools and the Graduate Division tell why they chose to study at UCSF, one of the nation's premier health sciences universities, in a new video captured during new student orientation day.</p>
-
Archive: Lawyer Turns Musician for UCSF Patients
-
Archive: Neural Stem Cell Study Arose from Culture of Collaboration That Drives Clinical Innovation
<p>A new study that represents a significant first step in exploring the potential of stem cells to treat neurological disease is a “natural outgrowth” of a longstanding culture of interdisciplinary collaboration in UCSF neonatology — a culture that UCSF Benioff Children's Hospital physicians David Rowitch and Donna Ferriero work hard to sustain.</p>
-
Archive: Transplanted Neural Stem Cells Produced Myelin, UCSF Study Shows
For the first time, a clinical trial led by UCSF investigators and sponsored by Stem Cells Inc., has shown that transplanted neural stem cells appear to produce myelin in the brains of four young children with an early-onset, fatal disease.
-
Archive: Sleep Key to Well-being, Expert Says
-
Archive: UCSF Set to Launch New Long Range Development Plan
<p>For the first time since 1997, UCSF is embarking on a new long-range development plan to guide the University through the year 2035 and is seeking input from members of the community in the planning process.</p>
-
Archive: Pesticides Blamed by Report for Illnesses
-
Archive: Why Are Doctors So Slow to Learn?
-
Archive: UC San Francisco Led Group Gets $10M to Study Advanced Prostate Cancer
-
Archive: Nobel Medicine Prize Goes to SF Scientist
-
Archive: Protein Deficiency in Brain Plays Key Role in Early-Onset Dementia
Scientists at the UCSF-affiliated Gladstone Institutes have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD) — a form of early-onset dementia similar to Alzheimer’s disease. These results lay the foundation for therapies that one day may benefit those who suffer from this and related brain diseases.
-
Archive: UCSF Researcher Awarded Nobel Prize in Medicine
-
Archive: Redefining Medicine with Apps and iPads
-
Archive: Researchers Map Gene 'Bursting' in Protein Production
Scientists at the UCSF-affiliated Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes — and revealing new clues as to what happens when this process goes awry.
-
Archive: Nobel Prize Winner Yamanaka Remains at Forefront of Fast-Moving Stem Cell Field He Galvanized
-
Archive: Prostate Cancer Dream Team Gets $10 Million Grant to Tackle Advanced Disease
Armed with a new $10 million grant, a multi-center “dream team’’ of scientists, led by UCSF, is embarking on a groundbreaking undertaking to overcome therapeutic resistance and revolutionize treatment for patients with advanced prostate cancer.
-
Archive: California Professor Honored with Nobel Prize
-
Archive: Good Eggs
-
Archive: Frequently Asked Questions About Stem Cell Science
<p>Here are answers to frequently asked questions about induced pluripotent stem cells, or iPS cells, the type of cell that has been reprogrammed from an adult cell, such as a skin or blood cell.</p>
-
Archive: Nobel Winners Unlocked Cells' Unlimited Potential
-
Archive: Are We Throwing away 'Expired' Medications Too Soon?
-
Archive: Nobel Prize in Medicine Awarded to Sir John Gurdon, Shinya Yamanaka
-
Archive: Shinya Yamanaka's Road to the 2012 Nobel Prize in Medicine
<p>Stem cell scientist Shinya Yamanaka, MD, PhD, gained international acclaim in 2006 when he developed the method for inducing skin cells from mice into becoming like pluripotent stem cells and called them iPS cells. Here's a look at his road to the 2012 Nobel Prize in Medicine.</p>
-
Archive: 2012 Nobel Prize Media Coverage
<p>Shinya Yamanaka, MD, PhD, a senior investigator at the Gladstone Institutes and a UCSF professor of anatomy, is making headlines across the world as winner of the 2012 Nobel Prize in Physiology or Medicine.</p>
-
Archive: Cloning and Stem Cell Discoveries Earn Nobel in Medicine
-
Archive: UCSF Researcher Wins Nobel Award